Journal for ImmunoTherapy of Cancer (Nov 2023)
1070 ‘Decoy-resistant’ IL-18 in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)